// App-Quantinova.ai

3930 : A prospective pilot study of kinetics of high sensitivity troponin T (hs-TnT) and amino terminal (nt-proBNP) in breast cancer patients (pts) treated with doxorubicin (A) or trastuzumab (T)

Researchers

Presenter

  • Pooja Advani

Principal Investigators

  • Jonathan Hoyne

  • Alvaro Moreno-Aspitia

  • Marcia Dubin

  • Shelly Brock

  • Caroline Harlow

  • Tammy Wollett

  • Saranya Chumsri

  • Joseph Blackshear

Medical Centers

  • Mayo Clinic, Jacksonville, FL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Myocardial infarction

  • Breast cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Trastuzumab

  • Doxorubicin

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • NCT01771549

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved